UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 344

Sortiert nach

Evaluation of the RABBIT Risk Score for serious infections

Annals of the rheumatic diseases, 2014-09, Vol.73 (9), p.1673-1676

2014

Volltextzugriff (PDF)

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1914-1920

2011

Volltextzugriff (PDF)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.504

2017

Volltextzugriff (PDF)

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2016-09, Vol.75 (9), p.1667-1673

2016

Volltextzugriff (PDF)

I Just Don’t Want to Be Judged: Cultural Capital’s Impact on Student Plagiarism

SAGE open, 2019-01, Vol.9 (1), p.215824401882238

Strangfeld, Jennifer A.

2019

Volltextzugriff (PDF)

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1583

2017

Volltextzugriff (PDF)

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis

Seminars in arthritis and rheumatism, 2020-02, Vol.50 (1), p.36-41

2020

Volltextzugriff (PDF)

RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis

Zeitschrift für Rheumatologie, 2020-03, Vol.79 (2), p.135-142

2020

Volltextzugriff (PDF)

Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center

Zeitschrift für Rheumatologie, 2020-12, Vol.79 (10), p.983-995

2020

Volltextzugriff (PDF)

Accessing Resistance Capital: First-generation Latina/o/x College Students in Higher Education

Journal of Latinos and education, 2024-03, Vol.23 (2), p.550-565

Strangfeld, Jennifer A.

2024

Volltextzugriff (PDF)

Perspectives for rheumatological health services research at the German Rheumatism Research Center

Zeitschrift für Rheumatologie, 2020-12, Vol.79 (10), p.1003

2020

Volltextzugriff (PDF)

Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report

Lupus, 2012-04, Vol.21 (4), p.386-401

2012

Volltextzugriff (PDF)

How do register data support clinical decision-making?

Zeitschrift für Rheumatologie, 2015-03, Vol.74 (2), p.119-124

2015

Volltextzugriff (PDF)

Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide

Annals of the rheumatic diseases, 2009-12, Vol.68 (12), p.1856-1862

2009

Volltextzugriff (PDF)

SAT0568 Initiation of Biologic Treatment over The Past 15 Years Reflects Changes in Treatment Strategies: Results from The Prospective Cohort of The German Biologics Register Rabbit

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.874-875

2016

Volltextzugriff (PDF)

THU0077 Insufficient Cardiovascular Treatment Is A Major Risk Factor for Stroke in Ra Patients: A Matched Case Control Study from The German Biologics Register Rabbit

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.207-207

2016

Volltextzugriff (PDF)

OP0260 Lower Intestinal Perforations Are More Frequent and Present Untypically in Patients Treated with Tocilizumab Compared To Other Biologic or Conventional Synthetic DMARDS

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.156-157

2016

Volltextzugriff (PDF)

OP0168 First Results from The Prospective German Pregnancy Register Rhekiss

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.119-119

2016

Volltextzugriff (PDF)

FRI0226 Tocilizumab Is Similarly Effective in RA Patients with No or Up To Two Prior Bdmard Failures: Results from The German Prospective Cohort Study Rabbit

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.514-515

2016

Volltextzugriff (PDF)

Medication treatment of rheumatoid arthritis with a history of malignancy. Epidemiological data

Zeitschrift für Rheumatologie, 2016-02, Vol.75 (1), p.22-31

2016

Volltextzugriff (PDF)

Epidemiologie und gegenwärtige Versorgung von Patienten mit muskuloskelettalen Erkrankungen--Überblick

Drug research, 2015-11, Vol.65 Suppl 1, p.S3

Strangfeld, A

2015

Volltextzugriff (PDF)

Influence of therapy on risk of cancer in rheumatoid arthritis. Pathophysiological principles

Zeitschrift für Rheumatologie, 2016-02, Vol.75 (1), p.13-21

2016

Volltextzugriff (PDF)

FRI0294 Biologic Monotherapy: A Treatment Option for Elderly RA Patients with Multimorbid Conditions

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.491

2014

Volltextzugriff (PDF)

OP0161 Discontinuation of Biologic Dmards Increases the Risk of Sepsis and Mortality After Serious Infection

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.130-130

2015

Volltextzugriff (PDF)

OP0017 Pregnancies in Patients with Rheumatoid Arthritis: Treatment Decisions, Course of the Disease, and Pregnancy Outcomes

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.70-71

2015

Volltextzugriff (PDF)

1 – 25 von 344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(221)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(162)
Science & Technology
(162)
Life Sciences & Biomedicine
(126)
Rheumatology
(115)
Male
(88)
Middle Aged
(76)
Adult
(72)
Female
(72)
Arthritis, Rheumatoid - Drug Therapy
(50)
Rheumatoid Arthritis
(41)
Aged
(40)
Antirheumatic Agents - Therapeutic Use
(37)
Patients
(35)
Registries
(31)
Technology
(30)
Risk Factors
(29)
Epidemiology
(28)
Antirheumatic Agents - Adverse Effects
(27)
Tumor Necrosis Factor-Tnf
(26)
Arthritis, Rheumatoid - Epidemiology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Evaluation of the RABBIT Risk Score for serious infections

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

I Just Don’t Want to Be Judged: Cultural Capital’s Impact on Student Plagiarism

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis

RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis

Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center

Accessing Resistance Capital: First-generation Latina/o/x College Students in Higher Education

Perspectives for rheumatological health services research at the German Rheumatism Research Center

Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report

How do register data support clinical decision-making?

Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide

SAT0568 Initiation of Biologic Treatment over The Past 15 Years Reflects Changes in Treatment Strategies: Results from The Prospective Cohort of The German Biologics Register Rabbit

THU0077 Insufficient Cardiovascular Treatment Is A Major Risk Factor for Stroke in Ra Patients: A Matched Case Control Study from The German Biologics Register Rabbit

OP0260 Lower Intestinal Perforations Are More Frequent and Present Untypically in Patients Treated with Tocilizumab Compared To Other Biologic or Conventional Synthetic DMARDS

OP0168 First Results from The Prospective German Pregnancy Register Rhekiss

FRI0226 Tocilizumab Is Similarly Effective in RA Patients with No or Up To Two Prior Bdmard Failures: Results from The German Prospective Cohort Study Rabbit

Medication treatment of rheumatoid arthritis with a history of malignancy. Epidemiological data

Epidemiologie und gegenwärtige Versorgung von Patienten mit muskuloskelettalen Erkrankungen--Überblick

Influence of therapy on risk of cancer in rheumatoid arthritis. Pathophysiological principles

FRI0294 Biologic Monotherapy: A Treatment Option for Elderly RA Patients with Multimorbid Conditions

OP0161 Discontinuation of Biologic Dmards Increases the Risk of Sepsis and Mortality After Serious Infection

OP0017 Pregnancies in Patients with Rheumatoid Arthritis: Treatment Decisions, Course of the Disease, and Pregnancy Outcomes

Suchergebnisse filtern